| Literature DB >> 28537696 |
Sher Singh Yadav1, Rohit Bhattar1, Lokesh Sharma2, Gautam Banga3, Trilok Chandra Sadasukhi4.
Abstract
AIMS: To study the ultra structural changes in bladder musculature in cases of BPE and their clinical relevance.Entities:
Keywords: Prostate; Prostatic Hyperplasia; Urinary Bladder
Mesh:
Year: 2017 PMID: 28537696 PMCID: PMC5734072 DOI: 10.1590/S1677-5538.IBJU.2016.0350
Source DB: PubMed Journal: Int Braz J Urol ISSN: 1677-5538 Impact factor: 1.541
Figure 1a) variant of normal Intercellular Junctions (x-16400); 1b) Myocytes with normal intercellular junction and protrusion junction (X-17000); 1c) normal Intercellular Junction (X-17600) this consists of two closely apposed 25-70nm wide gap sarcolemma lying parallel to each other for a length of up to 10μm with paired symmetrical dense plaques.
Preoperative (Baseline) comparison between groups.
| Characters | Group | N | Mean | Std. Deviation | ‘p’ Value | Significant difference from# |
|---|---|---|---|---|---|---|
| Age(in years) | Control (Group 1) | 21 | 60.19 | 3.49 | ||
| Case (Group2 A) | 20 | 62.35 | 5.70 | 0.289 | ||
| Case (Group2 B) | 9 | 62.56 | 5.66 | |||
| IPSS | Control (Group 1) | 21 | 3.14 | 1.46 | ||
| Case (Group2 A) | 20 | 20.45 | 3.90 | <0.001 | ||
| Case (Group2 B) | 9 | -+ | -+ | |||
| Flow Rate(Qmax) | Control (Group 1) | 21 | 17.29 | 2.62 | A,B | |
| Case (Group2 A) | 20 | 6.54 | 1.31 | <0.001 | 1,B | |
| Case (Group2 B) | 9 | 0.00+ | 0.00+ | 1,A | ||
| Prostate Size (in grams) | Control (Group 1) | 21 | 16.00 | 2.35 | A,B | |
| Case (Group2 A) | 20 | 59.15 | 11.85 | <0.001 | 1 | |
| Case (Group2 B) | 9 | 62.00 | 15.28 | 1 | ||
| PVR(in mL) | Control (Group 1) | 21 | 5.29 | 6.48 | A,B | |
| Case (Group2 A) | 20 | 88.35 | 50.14 | <0.001 | 1,B | |
| Case (Group2 B) | 9 | 400.00 | 242.38 | 1,A |
ANOVA Test; # Tukey HSD; + For patients on catheter drainage; Qmax were underleveled as 0, similarly as these patients were not able to recollect their IPSS, hence it was not calculated in this group.
Comparison of electron microscopic findings between groups and statistical correlations.
| Microscopic findings | Control (Group 1) | Case (Group 2) | Total Case (N=29) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| (N=21) | Catheter free (A) (N=20) | On catheter (B) (N=9) | |||||||
| No. | % | No. | % | No. | % | No. | % | ||
|
| |||||||||
| Normal | 18 | 85.71 | 4 | 20.00 | 1 | 11.11 | 5 | 17.24 | |
| Hypertrophy | 3 | 14.29 | 5 | 25.00 | 2 | 22.22 | 7 | 24.14 | |
| Degeneration | 0 | 0.00 | 5 | 25.00 | 3 | 33.33 | 8 | 27.59 | |
| Hypertrophy+Degeneration | 0 | 0.00 | 6 | 30.00 | 3 | 33.33 | 9 | 31.03 | |
|
| |||||||||
| Compact | 18 | 85.71 | 4 | 20.00 | 2 | 22.22 | 6 | 20.69 | |
| Intermediate | 3 | 14.29 | 2 | 10.00 | 2 | 22.22 | 4 | 13.79 | |
| Loose | 0 | 0.00 | 14 | 70.00 | 5 | 55.56 | 19 | 65.52 | |
|
| |||||||||
| Normal | 21 | 100.00 | 6 | 30.00 | 2 | 22.22 | 8 | 27.59 | |
| Collagen | 0 | 0.00 | 8 | 40.00 | 5 | 55.56 | 13 | 44.83 | |
| Elastin | 0 | 0.00 | 4 | 20.00 | 0 | 0.00 | 4 | 13.79 | |
| Collagen+Elastin | 0 | 0.00 | 2 | 10.00 | 2 | 22.22 | 4 | 13.79 | |
|
| |||||||||
| Absent | 21 | 100.00 | 16 | 80.00 | 7 | 77.78 | 23 | 79.31 | |
| Present | 0 | 0.00 | 4 | 20.00 | 2 | 22.22 | 6 | 20.69 | |
|
| |||||||||
| Normal | 21 | 100.00 | 9 | 45.00 | 5 | 55.56 | 14 | 48.28 | |
| Dysjunction Pattern | 0 | 0.00 | 11 | 55.00 | 4 | 44.44 | 15 | 51.72 | |
Figure 2Myohypertrophy (a-X-27600 and b-X-13000). Marked intercellular separation and cellular hypertrophy. Excessive collagen present between the cells as well as between the fascicles. Red arrow shows myohypertrophy and black arrow shows excessive collagen and 2b) shows myohypertrophy in obstructed bladder shown by red arrow and loose fascicle with increased intercellular space shown by black arrow (X-13200).
Figure 3Degenerative pattern (X-12800). Black arrow shows degenerative pattern.
Figure 4a) Widened intercellular spaces with excessive collagen deposition along with degenerative myocytes (X-25860) and 4b) Excessive collagen with hyperelastosis (X-22380) with black arrow shows collagen and red arrow shows elastin.
Figure 5Nerve hypertrophy (X-50220).
Statistical correlation of electron microscopic findings in various groups.
| Abnormality of electron microscopic pattern | Control (Group 1) v/s Cases (Group 2) | Control (Group 1) v/s Case (Group 2 A) | Control(Group 1) v/s Case (Group 2 B) | Case A v/s B (Group 2A v/s Group 2B) |
|---|---|---|---|---|
|
| <0.001 | <0.001 | <0.001 | 1.000 |
|
| <0.001 | <0.001 | <0.001 | 0.643 |
|
| <0.001 | <0.001 | <0.001 | 0.544 |
|
| 0.033 | 0.048 | 0.083 | 1.000 |
|
| <0.001 | <0.001 | 0.005 | 0.700 |
Chi-square Test;
Fisher Exact Test
Showing correlation of ultrastructural characterstics with IPSS and PVR.
| Ultrastructural characterstics | IPSS | PVR | |||||||
|---|---|---|---|---|---|---|---|---|---|
| <19 | >19 | Total | ‘p’ Value | <300mL | >300mL | Total | ‘p’ Value | ||
|
| Normal | 2 (22.22%) | 0 (0%) | 2 | 0.099344 | 5 (22.73%) | 0 (0%) | 5 | 0.165377 |
| Abnormal | 7 (77.78%) | 11 (100%) | 18 | 17 (77.27%) | 7 (100%) | 24 | |||
|
| Normal | 2 (22.22%) | 2 (18.18%) | 4 | 0.82218 | 4 (18.18%) | 2 (28.57%) | 6 | 0.555599 |
| Abnormal | 7 (77.78%) | 9 (81.82%) | 16 | 18 (81.82%) | 5 (71.43%) | 23 | |||
|
| Normal | 3 (33.33%) | 3 (27.27%) | 6 | 0.76857 | 6 (27.27%) | 2 (28.57%) | 8 | 0.946613 |
| Abnormal | 6 (66.67%) | 8 (72.73%) | 14 | 16 (72.73%) | 5 (71.43%) | 21 | |||
|
| Normal | 8 (88.89%) | 9 (81.82%) | 17 | 0.65952 | 17 (77.27%) | 6 (85.71%) | 23 | 0.631069 |
| Abnormal | 1 (11.11%) | 2 (18.18%) | 3 | 5 (22.73%) | 1 (14.29%) | 6 | |||
|
| Normal | 4 (44.44%) | 6 (54.55%) | 10 | 0.65309 | 11 (50%) | 3 (42.86%) | 14 | 0.741854 |
| Abnormal | 5 (55.56%) | 5 (45.45%) | 10 | 11 (50%) | 4 (57.14%) | 15 | |||
Chi-square Test
Post operative (at 3rd months) comparison between groups.
| Group | N | Mean | Std. Deviation | ‘p’ Value | Significant difference from | |
|---|---|---|---|---|---|---|
| IPSS | Control (Group 1) | 21 | 3.19 | 1.29 | A | |
| Case (Group 2A) | 20 | 6.65 | 4.40 | 0.003 | 1 | |
| Case (Group 2B) | 8 | 4.75 | 1.67 | – | ||
| Flow Rate(Qmax) | Control (Group 1) | 21 | 17.37 | 2.45 | A,B | |
| Case (Group 2 A) | 20 | 12.13 | 4.66 | <0.001 | 1 | |
| Case (Group 2 B) | 9 | 11.36 | 4.71 | 1 | ||
| Prostate Size(in grams) | Control (Group 1) | 21 | 16.00 | 2.35 | A,B | |
| Case (Group 2 A) | 20 | 24.30 | 3.85 | <0.001 | 1 | |
| Case (Group 2 B) | 9 | 23.56 | 4.95 | 1 | ||
| PVR (in mL) | Control (Group 1) | 21 | 5.33 | 5.83 | – | |
| Case (Group 2 A) | 20 | 13.70 | 26.2 | 0.061 | – | |
| Case (Group 2 B) | 9 | 59.78 | 132.17 | – |
ANOVA Test;
Tukey HSD;
one patient not able to void